129 related articles for article (PubMed ID: 31205501)
1. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C/D) in patients with gastric cancer and peritoneal metastasis: a phase II study.
Struller F; Horvath P; Solass W; Weinreich FJ; Strumberg D; Kokkalis MK; Fischer I; Meisner C; Königsrainer A; Reymond MA
Ther Adv Med Oncol; 2019; 11():1758835919846402. PubMed ID: 31205501
[TBL] [Abstract][Full Text] [Related]
2. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial).
Vizzielli G; Giudice MT; Nardelli F; Costantini B; Salutari V; Inzani FS; Zannoni GF; Chiantera V; Di Giorgio A; Pacelli F; Fagotti A; Scambia G
Ann Surg Oncol; 2024 Feb; 31(2):1207-1216. PubMed ID: 38099993
[TBL] [Abstract][Full Text] [Related]
3. Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.
Graversen M; Detlefsen S; Bjerregaard JK; Fristrup CW; Pfeiffer P; Mortensen MB
Ther Adv Med Oncol; 2018; 10():1758835918777036. PubMed ID: 29899763
[TBL] [Abstract][Full Text] [Related]
4. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
[TBL] [Abstract][Full Text] [Related]
5. Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma.
Khosrawipour T; Khosrawipour V; Giger-Pabst U
PLoS One; 2017; 12(10):e0186709. PubMed ID: 29049340
[TBL] [Abstract][Full Text] [Related]
6. Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study.
Teixeira Farinha H; Grass F; Kefleyesus A; Achtari C; Romain B; Montemurro M; Demartines N; Hübner M
Gastroenterol Res Pract; 2017; 2017():4596176. PubMed ID: 28316621
[No Abstract] [Full Text] [Related]
7. Modified scoring system for the quantitative assessment of histological regression in peritoneal carcinomatosis after pressurized intraperitoneal aerosol chemotherapy: A pilot study.
Abbas M; Ramspott JP; Chourio Barboza DE; Pascher A; Wardelmann E; Sporn JC
Oncol Lett; 2024 Jul; 28(1):308. PubMed ID: 38784603
[TBL] [Abstract][Full Text] [Related]
8. Pressurised Intraperitoneal Aerosolised Chemotherapy-Results from the First Hundred Consecutive Procedures.
Hoskovec D; Krška Z; Vočka M; Argalácsová S; Dytrych P
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672641
[TBL] [Abstract][Full Text] [Related]
9. Anaesthesia in a Toxic Environment: Pressurised Intraperitoneal Aerosol Chemotherapy: A Retrospective Analysis.
Rouche A; Hübner M; Grass F; Pache B; Demartines N; Blanc C
Turk J Anaesthesiol Reanim; 2020 Aug; 48(4):273-279. PubMed ID: 32864641
[TBL] [Abstract][Full Text] [Related]
10. Reply to Letter to the Editor Concerning "Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the USA".
Sullivan KM; Whelan RL; DePeralta D; Merchea A; Dellinger T; Raoof M
Ann Surg Oncol; 2024 Apr; 31(4):2408-2409. PubMed ID: 38245647
[No Abstract] [Full Text] [Related]
11. Complications in advanced or recurrent gastric cancer patients with peritoneal metastasis during and after palliative systemic chemotherapy.
Hamamoto Y
Mol Clin Oncol; 2015 May; 3(3):539-542. PubMed ID: 26137263
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
Guchelaar NAD; Nasserinejad K; Mostert B; Koolen SLW; van der Sluis PC; Lagarde SM; Wijnhoven BPL; Mathijssen RHJ; Noordman BJ
Br J Surg; 2024 May; 111(5):. PubMed ID: 38722803
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal Metastatic Gastric Cancer: Local Treatment Options and Recommendations.
Acs M; Piso P; Glockzin G
Curr Oncol; 2024 Mar; 31(3):1445-1459. PubMed ID: 38534942
[TBL] [Abstract][Full Text] [Related]
14. Regional Therapy Approaches for Gastric Cancer with Limited Peritoneal Disease.
Li AY; Sedighim S; Tajik F; Khan AM; Radhakrishnan VK; Dayyani F; Senthil M
J Gastrointest Cancer; 2024 Jan; ():. PubMed ID: 38277055
[TBL] [Abstract][Full Text] [Related]
15. PIPAC for Gastrointestinal Malignancies.
Daniel SK; Sun BJ; Lee B
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959264
[TBL] [Abstract][Full Text] [Related]
16. Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf.
Hübner M; Somashekhar SP; Teixeira Farinha H; Abba J; Rao RG; Alyami M; Willaert W
Ann Surg Open; 2022 Dec; 3(4):e203. PubMed ID: 37600288
[TBL] [Abstract][Full Text] [Related]
17. Novel Multi-Modal Therapies and Their Prognostic Potential in Gastric Cancer.
Chidambaram S; Guiral DC; Markar SR
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370723
[TBL] [Abstract][Full Text] [Related]
18. Pressurized intraperitoneal aerosol chemotherapy, reasons for interrupting treatment: a systematic review of the literature.
Ezanno AC; Malgras B; Pocard M
Pleura Peritoneum; 2023 Jun; 8(2):45-53. PubMed ID: 37304159
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence-The PIPAC-OPC4 Study.
Graversen M; Rouvelas I; Ainsworth AP; Bjarnesen AP; Detlefsen S; Ellebaek SB; Fristrup CW; Liljefors MG; Lundell L; Nilsson M; Pfeiffer P; Tarpgaard LS; Tsekrekos A; Mortensen MB
Ann Surg Oncol; 2023 Jul; 30(7):4433-4441. PubMed ID: 36867174
[TBL] [Abstract][Full Text] [Related]
20. Response Evaluation in Patients with Peritoneal Metastasis Treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
Roensholdt S; Detlefsen S; Mortensen MB; Graversen M
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
